SCHEMBL13486006

SCHEMBL13486006

c1ccc(-c2ccc(N(c3ccc(-c4ccc(N(c5ccc(-c6ccccc6)cc5)c5ccc(-c6ccccc6)cc5)c5ccccc45)cc3)c3ccc4c(c3)c3ccccc3n4-c3ccccc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ TSPO P30536 1/20 0.36
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ KMT2A Q03164 3/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ PTGER4 P35408 1/20 0.32
▸ MAPK8 P45983 1/20 0.31
▸ HSD17B10 Q99714 2/20 0.30
▸ RAC2 P15153 1/20 0.30
▸ RAC3 P60763 1/20 0.30
▸ CDC42 P60953 1/20 0.30
▸ RAC1 P63000 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13486080 1.00 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL13724240 1.00 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL13486018 0.99 L3MBTL1 (0.43) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL13485846 0.99 L3MBTL1 (0.43) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL24949964 0.99 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL13725643 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL13486082 0.95 L3MBTL1 (0.40) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL13486028 0.95 L3MBTL1 (0.40) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL13724797 0.95 L3MBTL1 (0.40) L3MBTL1KDM4EATMTSPORXRA
SCHEMBL13486010 0.95 L3MBTL1 (0.40) L3MBTL1KDM4EATMTSPORXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8298684-B2 Phenylcarbazole compounds, organic light emitting device comprising the phenylcarbazole compounds and flat panel display device comprising the organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2012-10-30 — — US disclosed
US-8298684-B2 Phenylcarbazole compounds, organic light emitting device comprising the phenylcarbazole compounds and flat panel display device comprising the organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2012-10-30 — — US disclosed
US-20100032656-A1 Phenylcarbazole compounds, organic light emitting device comprising the phenylcarbazole compounds and flat panel display device comprising the organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2010-02-11 — — US disclosed
US-20100032656-A1 Phenylcarbazole compounds, organic light emitting device comprising the phenylcarbazole compounds and flat panel display device comprising the organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032656-A1 Phenylcarbazole compounds, organic light emitting device comprising the phenylcarbazole compounds and flat panel display device comprising the organic light emitting device OCIAD1, OXA1L, MAP1LC3B L3MBTL1 1368/4885KDM4E 3067/4885ATM 3948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback